8.700USD+30.43%Mkt Cap: 72.84M USDP/E: —Last update: 2026-05-26
electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally.…
Industry Peers
Medical DevicesIndicators:|
Key Statistics
Company
Market Cap72.84M USD
Enterprise Value50.35M USD
Revenue (TTM)34.90M USD
Gross Profit27.79M USD
Net Income (TTM)-13.97M USD
Revenue/Share4.035 USD
Last Price8.700 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees83
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-10.89
PEG—
EV/EBITDA-3.53
EV/Revenue1.44
P/S1.42
P/B-8.56
EPS (TTM)-1.77
EPS (Forward)-0.55
52W Range
4.16090% of range9.230
52W High9.230 USD
52W Low4.160 USD
Profitability
Gross Margin86.75%
Oper. Margin-55.47%
EBITDA Margin-40.92%
Profit Margin-43.60%
ROE817.20%
ROA-74.82%
Growth
Revenue Growth42.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-8.19M USD
CapEx (TTM)66.00K USD
FCF Margin-3.91%
FCF Yield-1.88%
Net Debt655.00K USD
Net Debt/EBITDA-0.05
Balance Sheet
Debt/Equity-5.50
Current Ratio1.02
Quick Ratio0.79
Book Value/Sh-0.7000 USD
Cash/Share1.064 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateFeb 15, 2023
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)19.17 USD
Target Range12.00 USD – 26.00 USD
# Analysts5
Ownership
Shares Out.8.30M
Float5.22M
Insiders37.19%
Institutions9.18%
Short Interest
Short Ratio5.2d
Short % Float4.36%
Short % Out.4.12%
Shares Short334.86K
Short (prev mo.)292.00K
Technical
SMA 506.369 (+36.6%)
SMA 2005.704 (+52.5%)
Beta—
S&P 52W Chg28.31%
Avg Vol (30d)73.67K
Avg Vol (10d)70.86K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—